Dolby Laboratories (NYSE:DLB – Get Free Report) CFO Robert Park sold 4,895 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total transaction of $277,448.60. Following the sale, the chief financial officer directly owned 81,490 shares of the company’s stock, valued at approximately $4,618,853.20. This trade represents a 5.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Dolby Laboratories Stock Performance
DLB stock opened at $54.75 on Friday. Dolby Laboratories has a one year low of $53.45 and a one year high of $77.59. The company’s fifty day moving average price is $61.32 and its 200-day moving average price is $63.85. The company has a market capitalization of $5.18 billion, a PE ratio of 21.64 and a beta of 0.86.
Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.31 by $0.06. The company had revenue of $395.63 million during the quarter, compared to analysts’ expectations of $385.80 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. Dolby Laboratories’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the company posted $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, research analysts predict that Dolby Laboratories will post 3.22 EPS for the current fiscal year.
Dolby Laboratories Dividend Announcement
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on DLB shares. Rosenblatt Securities restated a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a report on Friday, January 30th. Barrington Research reaffirmed an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, April 27th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Finally, Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, January 31st. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $90.75.
Get Our Latest Report on Dolby Laboratories
Institutional Investors Weigh In On Dolby Laboratories
Several large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its stake in shares of Dolby Laboratories by 2.7% in the 3rd quarter. Vanguard Group Inc. now owns 7,756,924 shares of the electronics maker’s stock valued at $561,369,000 after purchasing an additional 203,411 shares during the last quarter. State Street Corp raised its holdings in Dolby Laboratories by 8.7% during the 2nd quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after buying an additional 180,072 shares during the period. First Trust Advisors LP raised its holdings in Dolby Laboratories by 19.9% during the 1st quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock valued at $135,431,000 after buying an additional 374,405 shares during the period. Geode Capital Management LLC lifted its position in Dolby Laboratories by 15.6% in the fourth quarter. Geode Capital Management LLC now owns 1,885,246 shares of the electronics maker’s stock worth $122,749,000 after buying an additional 254,250 shares during the last quarter. Finally, AQR Capital Management LLC lifted its position in Dolby Laboratories by 51.8% in the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after buying an additional 592,282 shares during the last quarter. 58.56% of the stock is owned by institutional investors.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record Highs
- 2 Ways to Play the Big Pharma Patent Cliff
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
